StockData
Eloxx Pharmaceuticals, Inc. logo

Eloxx Pharmaceuticals, Inc. (ELOX) stock

ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$10.41−1.33 (-11.33%)

Close on Nov 18, 2026Market cap $70.68MP/E –Yield –

Eloxx Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Eloxx Pharmaceuticals's price to sales ratio was 0.0× on Feb 27, 2026.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Feb 27, 20260.0×−0.0
2025Dec 31, 20250.0×–

More Eloxx Pharmaceuticals figures

See a number that looks wrong?